Core Laboratories Return on Equity (ROE) Growth & History (CLB)
Core Laboratories's return on equity was 11.58% for fiscal 2025.
View full Core Laboratories company overviewCore Laboratories annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 11.58% | −1.75 pp |
| 2024 | 2024-12-31 | 13.32% | −4.61 pp |
| 2023 | 2023-12-31 | 17.93% | +6.66 pp |
| 2022 | 2022-12-31 | 11.27% | — |
Core Laboratories quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.20% | −1.93 pp |
| Q1 2026 | 2026-03-31 | −0.30% | −0.23 pp |
| Q4 2025 | 2025-12-31 | 1.84% | −1.14 pp |
| Q3 2025 | 2025-09-30 | 5.35% | +0.56 pp |
| Q2 2025 | 2025-06-30 | 4.13% | +0.31 pp |
| Q1 2025 | 2025-03-31 | −0.06% | −1.47 pp |
| Q4 2024 | 2024-12-31 | 2.98% | +2.00 pp |
| Q3 2024 | 2024-09-30 | 4.78% | +0.26 pp |
| Q2 2024 | 2024-06-30 | 3.82% | — |
| Q1 2024 | 2024-03-31 | 1.41% | — |
| Q4 2023 | 2023-12-31 | 0.98% | — |
| Q3 2023 | 2023-09-30 | 4.53% | — |
Core Laboratories return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Core Laboratories's return on equity increased from 11.27% to 11.58%, a change of +0.31 percentage points. The latest reported quarter, Q2 2026, shows 2.20%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Laboratories source filings ↗